Cancer immunotherapy comes of age and looks for maturity

Amanda Finck; Saar I. Gill; Carl H. June

doi:10.1038/s41467-020-17140-5

Nature Communications (Jul 2020)

Cancer immunotherapy comes of age and looks for maturity

Amanda Finck,
Saar I. Gill,
Carl H. June

Affiliations

Amanda Finck: Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania
Saar I. Gill: Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania
Carl H. June: Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania

DOI: https://doi.org/10.1038/s41467-020-17140-5
Journal volume & issue: Vol. 11, no. 1
pp. 1 – 4

Abstract

Read online

As Nature Communications celebrates a 10-year anniversary, the field has witnessed the transition of cancer immunotherapy from a pipe dream to an established powerful cancer treatment modality. Here we discuss the opportunities and challenges for the future.

Published in Nature Communications

ISSN: 2041-1723 (Online)
Publisher: Nature Portfolio
Country of publisher: United Kingdom
LCC subjects: Science
Website: https://www.nature.com/ncomms/

About the journal